10.33
+1.87%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Profound Medical
Its shares trade on Toronto Stock Exchange under the ticker PRN.TO. It has been listed since 24 September 2014. In the fiscal year to 31 December 2025, it reported revenue of $16.4m and a net loss of $43.3m. At that date it held total assets of $140.6m and shareholders' equity of $66.3m.
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario. The company went IPO on 2014-09-24. focused on customizable, incision-free therapies which combine real-time magnetic resonance imaging (MRI), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The Company’s products include TULSA-PRO System and SONALLEVE. The TULSA-PRO is used to ablate benign or malignant prostate tissue in patients with a variety of prostate diseases. Prostate diseases include prostate cancer and benign prostatic hyperlasia (BPH). Prostate cancer is one of the common types of cancer affecting men. TULSA-PRO and SONALLEVE share the common technological concept of using MRI to enable visualization of the surgeon desired tissue in real time. Both products also use thermal ultrasound technology to heat and ablate tissue.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 24 Sept 2014
- Employees
- 109
- Website
- profoundmedical.com ↗
Leadership
Pay as last reported
- Dr. Arun MenawatChairman of the Board, Chief Executive Officer, since 2015$2.5m
- Dr. Mathieu BurtnykPresident$1.4m
- Mr. Rashed DewanChief Financial Officer$1.3m
- Mr. Tom TamberrinoChief Commercial Officer$1.1m
- Mr. Brian EllacottNon-Executive Independent Director$95,968
- Dr. Cynthia LavoieNon-Executive Independent Director$90,968
- Ms. Murielle LortieNon-Executive Independent Director$93,468
- Dr. Arthur RosenthalNon-Executive Independent Director$95,968
- Mr. Kris ShahNon-Executive Independent Director$90,968
- Mr. Stephen KilmerInvestor Relations
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 36
- Environment
- 38
- Social
- 52
- Governance
- 19
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Profound Medical Corp has a strong track record of technological innovation in the field of medical devices, particularly in the area of non-invasive surgical technologies. This has enabled the company to develop groundbreaking products that have revolutionized patient care.
- The company possesses an extensive intellectual property portfolio, including patents, trademarks, and trade secrets, which provides a significant competitive advantage in the market. This helps protect their innovative technologies from being replicated by competitors.
- Profound Medical Corp is led by a highly experienced management team with deep industry knowledge and expertise. Their collective leadership skills and strategic vision have played a crucial role in driving the company's growth and success.
Weaknesses
- Despite their innovative products, Profound Medical Corp faces the challenge of limited market reach, primarily due to the niche nature of their target market. This may impact their revenue potential and hinder their ability to scale up rapidly.
- Developing advanced medical technologies requires substantial investment in research and development. Profound Medical Corp may face challenges in consistently funding these activities, especially during economic downturns, which could impact their ability to stay at the forefront of innovation.
- As a medical device company, Profound Medical Corp heavily relies on regulatory approvals from various authorities. Any delays or difficulties in obtaining necessary approvals can significantly impact their product launch timelines and overall market competitiveness.
Opportunities
- The market for non-invasive surgical technologies is on the rise, driven by increasing patient preference for minimally invasive procedures and improvements in healthcare infrastructure. Profound Medical Corp can capitalize on this trend by expanding their product offerings and capturing a larger market share.
- With their innovative products, Profound Medical Corp can enter emerging markets where there is a growing need for advanced medical technologies. These markets offer significant growth potential and can diversify the company's revenue streams.
- Forming strategic partnerships and collaborations with healthcare organizations, research institutions, and key opinion leaders can provide Profound Medical Corp with access to expertise, resources, and a wider customer base. This can enhance their market presence and accelerate product development.
Threats
- The medical device industry is highly competitive, with numerous established players and new entrants vying for market share. Profound Medical Corp faces the risk of intense competition, which may result in price pressure, reduced profit margins, and the need for continuous innovation.
- Strict regulations and compliance requirements in the healthcare industry pose challenges to Profound Medical Corp. The company needs to ensure full compliance with regulatory standards and adapt quickly to any changes, as non-compliance can lead to penalties, reputational damage, and potential product recalls.
- The medical device industry is characterized by rapid technological advancements. There is a risk that Profound Medical Corp's innovative products may become obsolete if they fail to keep up with emerging technologies. The company needs to invest in research and development to stay at the forefront of industry trends.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.